Scholar

Cary P. Gross

H-index: 78
Economics 51%
Public Health 22%
mlbarnett.bsky.social
New paper w/ Brian McGarry, Ashvin Gandhi, and Drew Wilcock in @jamainternalmed.com!

Hospitals are complaining across the US that patients are "stuck" waiting for rehab beds at nursing homes when they are medically stable and ready for discharge. What is going on??

jamanetwork.com/journals/jam...
Question Has hospital length of stay increased more for Medicare
Advantage beneficiaries than for traditional Medicare beneficiaries
since the COVID-19 pandemic?Findings In this cohort study involving more than 89 million
hospitalizations from 2017 to the third quarter of 2023, Medicare
Advantage beneficiaries experienced disproportionately greater
increases in extended hospital stays, especially among those
discharged to skilled nursing facilities.Meaning These findings suggest that the Medicare Advantage
plan design and practices may contribute to hospital discharge
delays, with implications for patient outcomes and hospital
capacity as enrollment continues to rise.
meganranney.bsky.social
I have a list of things we can do to change this tempo of tragedy

The proposals are based on real data
They have had signals of efficacy

It may feel hopeless today but:

I refuse to give up.

Because - Our babies & our communities deserve better than a rolling litany of horrors.

by Fumiko ChinoReposted by: Cary P. Gross

fumikochino.bsky.social
#Medicaldebt is an indicator of an inherent failure of our health system to protect the most vulnerable. Aggressively pursuing it does little to serve the financial bottom line of a hospital, while exposing the most vulnerable & their families to a lifetime of downstream consequences.

@jama.com
prasad.bsky.social
few outcomes, except for 99% of FDA-approved drugs, 174 recipients of 104 Nobel Prizes, training ~30K MDs and ~10K PhDs per year to enter the workforce, and a 34% reduction in age-adjusted cancer deaths since 1990 -- the largest decrease in history
drugmonkey.bsky.social
Now do the Department of Defense budget, Andrew.

“Washington has thrown billions at NIH for decades with little accountability and few measurable outcomes,” HHS spokesperson Andrew Nixon said in a statement to Future Pulse.

www.politico.com/newsletters/...
NIH spending battle’s ripple effect
www.politico.com
drugmonkey.bsky.social
Now do the Department of Defense budget, Andrew.

“Washington has thrown billions at NIH for decades with little accountability and few measurable outcomes,” HHS spokesperson Andrew Nixon said in a statement to Future Pulse.

www.politico.com/newsletters/...
NIH spending battle’s ripple effect
www.politico.com

Reposted by: Cary P. Gross

davelevitan.bsky.social
From a source inside the National Cancer Institute:

“Everyone is scrambling to figure out how we’re supposed to work to serve the public when we can’t engage at all.”
leorahorwitzmd.bsky.social
Heard from #AHRQ that the entire grants staff has been let go! They are unable to issue funds for grants already funded, let alone fund new grants. This is outrageous and will make Americans poorer and sicker. Why? A brief thread about just some recent AHRQ-funded research: #MedSky #HealthPolicy

Reposted by: Cary P. Gross

jamainternalmed.com
Among FDA anticancer drug approvals from 2009 to 2020, only 27 next-in-class drugs had direct randomized clinical trial comparisons with first-in-class drugs. https://ja.ma/3Gs6k1J
Figure.  Network Diagram of Randomized Clinical Trials That Have Tested an Approved Next-In-Class Anticancer Drug Against an In-Class Comparator (N = 27)
lenasun.bsky.social
As a longtime public health reporter covering the rise of anti-vaccine groups, I have seen them use personal stories to raise doubts about vaccines.
Today I saw immunization advocates push back by highlighting the stories of the toll of vaccine-preventable illness. A thread:
maxwellfrost.bsky.social
I just left the Everglades Immigrant Interment Camp. No, I’m not using their ridiculous name. It was a very tough to witness humans in those cages. Every Floridian should be ashamed that our taxpayer money is being used for this.

Reposted by: Cary P. Gross

billgates.bsky.social
The facts are simple and devastating: Aid cuts have already cost lives, and the number of deaths will continue to rise. Here’s the evidence. ​
yalesph.bsky.social
America's health data system is fragmented, outdated, and hard to access. This slows the response to emerging health threats. PopHIVE unites diverse partners and data in one location, creating a solution for improved public health data for action.

4/5 @meganranney.bsky.social
“National health data has been too fragmented and too slow for too long. PopHIVE changes that.” - Dean Megan L. Ranney
PopHIVE unites diverse partners and data in one location, creating a solution for improved public health data for action.

Reposted by: Cary P. Gross

ameracadpeds.bsky.social
Hepatitis B can be passed from parent to baby at birth - and when that happens, the consequences can be deadly. It is unscientific and dangerous to intentionally ignore the success of U.S. vaccination programs or argue that the U.S. should not vaccinate babies for hepatitis B at birth.
ncspyale.bsky.social
Proud to celebrate our Yale NCSP 2025 graduates! 🎉 Their leadership & commitment to improving healthcare will make a real difference. #NCSP #YaleNCSP

@carygross.bsky.social @reshmagar.bsky.social @jsross119.bsky.social @ebronurse.bsky.social
hollylynchez.bsky.social
Makary makes many claims here that sound like "common sense" but are problematic.
1st he says FDA's reg reqs have made the US "less competitive in the global race for new drugs and treatments." I'm not aware of any sponsor planning to skip the US market.
www.washingtonpost.com/opinions/202...
Opinion | How we plan to cut FDA drug approval time by months
Qualifying manufacturers will be able to submit some data while clinical trials are ongoing.
www.washingtonpost.com

Reposted by: Cary P. Gross

yalesph.bsky.social
In a new study, Yale researchers, including Profs. Xiaomei Ma and Kai Chen, found that ozone pollution, also called smog, and high temperatures together increase the risk of acute myocardial infarction, commonly known as a heart attack. Learn more ⬇️
news.yale.edu/2025/0...
Star music, Kavli kudos, and summertime heart risks
Researchers listen to “music” made by stars, consider the heart risks of hot, smoggy days, and earn kudos in geoscience, public health, and systems biology.
news.yale.edu

Reposted by: Cary P. Gross

gregggonsalves.bsky.social
We're doing a live-fact-check of Bhattacharya and Senators on Tuesday! Join us!

Reposted by: Cary P. Gross

yalecancer.bsky.social
Lauren Cueto and @carygross.bsky.social shared new research from the Yale COPPER Center at #ASCO25 highlighting the time between study completion and publication/data sharing for NCI cooperative group trials.
meetings.asco.org/2025-asco-an...
@yaleschoolofmed.bsky.social @ascocancer.bsky.social

Reposted by: Cary P. Gross

thewonkologist.bsky.social
🚨🚨🚨
Presenting our new study on Medicare Advantage at #ASCO25! Lower use of low value cancer care among Medicare Advantage beneficiaries.

Simultaneously published in JCO
👇🏼👇🏼👇🏼
ascopubs.org/doi/10.1200/...
dusetzinas.bsky.social
Excited to share new work in @jama.com on launch prices for cancer drugs in Medicare Part D. Prices are going up, but no trend change post-IRA. Mean monthly launch prices increased from $10,954 in 2012-2014 to $27,891 in 2023-2025. Many thanks to @arnoldventures.bsky.social for funding this work!
Trends in Launch Prices and Price Increases for Self-Administered Anticancer Drugs in Medicare
This study examines trends in launch prices and price increases for anticancer therapies covered under Medicare Part D and approved from 2010 to 2024.
jamanetwork.com

Reposted by: Cary P. Gross

jamainternalmed.com
📢 Are you at #SGIM25? @societygim.bsky.social

Check out these Reviews relevant to you, curated by our editors. 🧵

References

Fields & subjects

Updated 1m